Legal Representation
Attorney
Nancy DiConza
USPTO Deadlines
Next Deadline
2512 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20021105)
Due Date
November 05, 2032
Grace Period Ends
May 05, 2033
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 27, 2023 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Oct 27, 2023 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | Loading... |
| Oct 27, 2023 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Oct 27, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| May 2, 2023 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Nov 5, 2021 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Nov 12, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 12, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 12, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Nov 12, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 12, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 12, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 5, 2017 | CORV | 1 | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | Loading... |
| Jan 31, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 26, 2013 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Jan 26, 2013 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Jan 26, 2013 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Jan 26, 2013 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 10, 2013 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| May 12, 2009 | C15P | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Apr 29, 2009 | 815F | I | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | Loading... |
| May 1, 2009 | PLGL | A | ASSIGNED TO PARALEGAL | Loading... |
| Apr 29, 2009 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Dec 18, 2007 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Nov 5, 2002 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 13, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 13, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 24, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 13, 2002 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 13, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 4, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 23, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 21, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 18, 2001 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Apr 23, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 8, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 13, 2000 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Sep 11, 2000 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
proteins for scientific and research use; [ chemical preparations for use in protein analysis; ] [ chemicals and chemical preparations for use in the manufacture of pharmaceuticals; proteins for immunoassay for detection of cancer, ] [ autoimmune disease, infection, ] [ cardiovascular disease, ] [ liver dysfunction, kidney dysfunction, ] [ inflammatory disease; ] [ and for toxicological studies for scientific use; proteins for biotechnological purposes, namely, chromatography; ] [ binding proteins and immunoassay reagents contained in boxes, trays or other receptacles, sold together as a unit, for scientific use ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
[ diagnostic proteins for clinical or medical laboratory analysis; ] proteins for therapeutic use for treating cancer, [ autoimmune disease, infection, ] cardiovascular disease, [ liver dysfunction, kidney dysfunction, toxicological conditions ] and inflammatory disease; biopharmaceuticals for use in cancer, [ autoimmune disease, infection, ] cardiovascular disease, [ liver dysfunction, kidney dysfunction, ] inflammatory disease; [ and toxicological conditions; ] [ laboratory testing kits for clinical or medical purposes comprising a box, tray or other receptacle holding vials containing binding proteins and immunoassays reagents, sold together as a unit ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 009
[ laboratory testing kits for research purposes comprising a box, tray or other receptacle holding vials containing binding proteins and immunoassay reagents, sold together as a unit ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Contract manufacturing of antibodies for third parties
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research and pharmaceutical drug development services, for others
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
009
040
042